Nome |
# |
New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation, file e31e124e-7a36-987f-e053-3705fe0a095a
|
470
|
Vitamin D and ovarian reserve: making clinical decisions, file e31e124e-d5fe-987f-e053-3705fe0a095a
|
168
|
Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count, file e31e124e-07dc-987f-e053-3705fe0a095a
|
166
|
A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF/ICSI cycles, file e31e124f-3e8e-987f-e053-3705fe0a095a
|
161
|
LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling, file e31e124b-3353-987f-e053-3705fe0a095a
|
159
|
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial, file e31e124f-8023-987f-e053-3705fe0a095a
|
142
|
How much variation in oocyte yield after controlled ovarian stimulation can be explained? A multilevel modelling study, file e31e124e-737b-987f-e053-3705fe0a095a
|
140
|
Future perspectives of PoseidOn stratification for clinical practice and research, file e31e124e-9e14-987f-e053-3705fe0a095a
|
137
|
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status., file e31e124a-a3fe-987f-e053-3705fe0a095a
|
128
|
Ovarian reserve markers to identify poor responders in the context of poseidon classification, file e31e124e-3a0d-987f-e053-3705fe0a095a
|
126
|
How Much Does AMH Really Vary in Normal Women?, file e31e124e-10c0-987f-e053-3705fe0a095a
|
122
|
Adnexal Torsion during Pregnancy after Oocyte In Vitro Maturation and Intracytoplasmic Sperm Injection Cycle., file e31e124e-12c6-987f-e053-3705fe0a095a
|
120
|
External validation of anti-Müllerian hormone based prediction of live birth in assisted conception, file e31e124e-0596-987f-e053-3705fe0a095a
|
107
|
Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol, file e31e124e-0677-987f-e053-3705fe0a095a
|
105
|
How to personalize ovarian stimulation in clinical practice, file e31e124f-11ae-987f-e053-3705fe0a095a
|
88
|
Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival, file e31e124f-9f88-987f-e053-3705fe0a095a
|
82
|
Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes, file e31e124f-7596-987f-e053-3705fe0a095a
|
65
|
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI), file e31e124e-babb-987f-e053-3705fe0a095a
|
63
|
A novel transnational fresh oocyte donation (TOD) program based on transport of frozen sperm and embryos, file e31e124e-b8c1-987f-e053-3705fe0a095a
|
47
|
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?, file 4c9cb431-a27c-4c00-b607-d42814784bb3
|
34
|
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients, file 972805b8-ec9e-4bd1-ab31-6a95bc760c99
|
28
|
Evaluation of the treatment with D-chiroinositol on levels of oxidative stress in PCOS patients, file 2032da9e-dded-4853-b0b3-42807d8a075d
|
26
|
Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study, file 1653da87-793b-4d72-8537-6f07ad6f0b2d
|
22
|
ESHRE guideline: ovarian stimulation for IVF/ICSI†, file 62d40a87-52d9-40ee-8497-0fa894425fa6
|
21
|
Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles, file e31e1250-87e3-987f-e053-3705fe0a095a
|
16
|
De novo
variants and recombination at 4q35: hints for preimplantation genetic testing in facioscapulohumeral muscular dystrophy, file 1a0852e2-f9ea-4a8b-b4a9-960c3d1b07ad
|
14
|
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome, file 48dc33c8-e336-4e73-a381-e57fec9410b1
|
14
|
Müllerian-inhibiting substance in women with polycystic ovary syndrome: Relationship with hormonal and metabolic characteristics, file e5da0958-b81b-4468-891b-a2f69bf1812e
|
14
|
Testicular pain as an unusual presentation of COVID-19: a brief review of SARS-CoV-2 and the testis, file 057d11fb-37f5-42db-a54d-03a503a406cd
|
13
|
Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome, file 7782f2f1-15c1-400d-9be6-3ca8ad128cd2
|
9
|
Age-specific nomogram for the decline in antral follicle count throughout the reproductive period, file e31e124d-4b09-987f-e053-3705fe0a095a
|
9
|
Effect of metforim on insulin-like growth factor (IGF) I and IGF-Binding protein I in polycystic ovary syndrome, file 7e1c1bc4-3f9a-4f12-8b86-c4dd124a2d0a
|
8
|
Effects of human chorionic gonadotropin administration on testicular testosterone secretion during prolonged exercise, file e31e124d-4b17-987f-e053-3705fe0a095a
|
8
|
Quantitative determination of sst2 and sst5 gene expression in uterine leiomyomata and the effect of treatment with somatostatin analogue, file 1eb1254d-f562-404f-a130-7a8a59c9b99c
|
7
|
Treatment algorithms for high responders: What we can learn from randomized controlled trials, real-world data and models, file 3e38c9e4-3dfe-42b7-80e5-4f8c5e922c50
|
7
|
Letter to editor, file 4a0790c0-76e0-4b8e-8228-6748c488aaa6
|
7
|
Hemodynamic effect of danazol therapy in women with uterine leiomyomata, file 5abba411-1811-4b1f-8439-42fcd6e9c71b
|
7
|
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV, file a0244041-f32f-4918-8de0-09ba53fe4be6
|
7
|
Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata, file a078fccf-c354-4f9d-9de2-021023f9e646
|
6
|
Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS, file 04d6e532-655c-44c2-b7f3-315a7f88ab52
|
5
|
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing IVF/ICSI, file d90a7134-c4e0-48a7-877f-13dbea736a83
|
5
|
Perinatal and obstetric outcomes in singleton pregnancies following fresh versus cryopreserved blastocyst transfer: a meta-analysis, file 57c81bd1-4634-432d-aee1-a96dc0aea603
|
4
|
Insulin sensitizing agents and their effect on adrenal androgens?: the reply, file a378d3f4-df85-41a9-94ee-ef82366288ad
|
4
|
Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays, file be268f25-afe9-480d-8f19-0a86dacb11da
|
4
|
COVID-19 and assisted reproductive technology services: Repercussions for patients and proposal for individualized clinical management, file 049dd5af-b9d2-44d4-8572-bd371731f2d7
|
3
|
Erratum: Metformin treatment reduces ovarian cytochrome P-450c17α response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome (Hum. Reprod. (2000) 15 (21-23)), file 1c02301d-cf48-4e62-a41c-5a98325b0caa
|
3
|
Reference values in ovarian response to controlled ovarian stimulation throughout the reproductive period, file 5093681e-eea7-4240-ae0e-6e4c1294e508
|
3
|
Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007–2017), file 61fc315c-48ff-441c-b0a4-09db5cc1d4d8
|
3
|
Developing a core outcome set for future infertility research: an international consensus development study, file fbe9a1ee-5e52-428c-b29d-0cc38940fded
|
3
|
Developing a core outcome set for future infertility research: An international consensus development study, file a554045f-aa79-44d3-a31a-119dcf501ba9
|
2
|
MATER protein as substrate of PKCepsilon in human cumulus cells., file e31e124a-a055-987f-e053-3705fe0a095a
|
2
|
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)., file e31e124a-a206-987f-e053-3705fe0a095a
|
2
|
Anti-Mullerian hormone (AMH): what do we still need to know?, file e31e124a-b21c-987f-e053-3705fe0a095a
|
2
|
Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization, file e31e124b-2c81-987f-e053-3705fe0a095a
|
2
|
Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles, file e31e124d-52ac-987f-e053-3705fe0a095a
|
2
|
The performance of the Elecsys® anti-Müllerian hormone assay in predicting extremes of ovarian response to corifollitropin alfa, file f2c7ded3-703d-4143-9452-10e646886ee6
|
2
|
FSHR polymorphism p.N680S mediates different responses to FSH in vitro, file e31e124b-1705-987f-e053-3705fe0a095a
|
1
|
The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age, file e31e124b-2d79-987f-e053-3705fe0a095a
|
1
|
Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology, file e31e124d-538d-987f-e053-3705fe0a095a
|
1
|
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH), file e31e124e-cc77-987f-e053-3705fe0a095a
|
1
|
Evidence for expression and functionality of FSH and LH/hCG receptors in human endometrium, file e31e124f-0a18-987f-e053-3705fe0a095a
|
1
|
Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays, file e31e124f-1ef0-987f-e053-3705fe0a095a
|
1
|
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause, file ef1870d8-dbcb-446e-8bf3-4c69cf44a980
|
1
|
Totale |
2.931 |